{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:29:28Z","timestamp":1762918168297,"version":"3.37.3"},"reference-count":14,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"43","license":[{"start":{"date-parts":[[2020,10,23]],"date-time":"2020-10-23T00:00:00Z","timestamp":1603411200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"National Science and Technology Major Projects for major new drugs innovation and development","award":["2017ZX09304028"],"award-info":[{"award-number":["2017ZX09304028"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Chemotherapeutic agents of direct cell damage play a role in initiating thrombotic microangiopathy (TMA), however still being underdiagnosed. Decitabine (DAC) is a pyrimidine analogue of the nucleoside cytidine, which can lead to injury to endothelium. Biopsy-proven DAC-induced kidney injury is rare.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Patient concerns:<\/jats:title>\n            <jats:p>A 47-year-old Chinese man with membranous nephropathy presented recurrent edema and acute kidney injury after a 3-day course of low dose DAC infusion because of cyclophosphamide-relating thrombocytopenia.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Diagnosis:<\/jats:title>\n            <jats:p>Laboratory data revealed nephrotic syndrome, hematuria, renal glycosuria and hypokalemia with hyperchloridemia. Renal pathological findings revealed TMA with secondary glomerular crescents formation (28%), partial foot process effacement and acute tubular necrosis. A diagnosis of DAC-induced renal TMA was considered.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Interventions:<\/jats:title>\n            <jats:p>As DAC had been timely discontinued before admission, the patient only received supportive treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Outcomes:<\/jats:title>\n            <jats:p>The patient achieved rapid remission of acute kidney injury after DAC withdrawal, and his serum creatinine further decreased to normal level after 6 months.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Careful monitoring of renal function especially serum creatinine should be emphasized during DAC treatment.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/md.0000000000022901","type":"journal-article","created":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T01:05:35Z","timestamp":1603501535000},"page":"e22901","source":"Crossref","is-referenced-by-count":4,"title":["Decitabine-induced kidney thrombotic microangiopathy with glomerular crescents formation and tubular necrosis"],"prefix":"10.1097","volume":"99","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3502-9829","authenticated-orcid":false,"given":"Ai-bo","family":"Qin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,10,23]]},"reference":[{"key":"R1-20230916","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","article-title":"Drug-induced thrombotic microangiopathy: a systematic review of published reports","volume":"125","author":"Al-Nouri","year":"2015","journal-title":"Blood"},{"key":"R2-20230916","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1053\/j.ajkd.2015.02.340","article-title":"Thrombotic microangiopathy, cancer, and cancer drugs","volume":"66","author":"Izzedine","year":"2015","journal-title":"American journal of kidney diseases: the official journal of the National Kidney Foundation"},{"key":"R3-20230916","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1053\/j.ajkd.2012.09.020","article-title":"Kidney complications of hematopoietic stem cell transplantation","volume":"61","author":"Singh","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"R4-20230916","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1007\/BF02135399","article-title":"5-Azacytidine, a new, highly effective cancerostatic","volume":"20","author":"Sorm","year":"1964","journal-title":"Experientia"},{"key":"R5-20230916","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/cncr.21792","article-title":"Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study","volume":"106","author":"Kantarjian","year":"2006","journal-title":"Cancer"},{"key":"R6-20230916","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/leu.2017.186","article-title":"A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia","volume":"32","author":"Santini","year":"2018","journal-title":"Leukemia"},{"key":"R7-20230916","first-page":"4831","article-title":"Phase I and pharmacokinetic study of 5-aza-2\u2019-deoxycytidine (NSC 127716) in cancer patients","volume":"46","author":"van Groeningen","year":"1986","journal-title":"Cancer Res"},{"key":"R8-20230916","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1182\/blood-2003-03-0687","article-title":"Phase 1 study of low-dose prolonged exposure schedules of the hypomethylating agent 5-aza-2\u2019-deoxycytidine (decitabine) in hematopoietic malignancies","volume":"103","author":"Issa","year":"2004","journal-title":"Blood"},{"key":"R9-20230916","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1200\/JCO.2000.18.5.956","article-title":"Low-dose 5-aza-2\u2019-deoxycytidine, a DNA hypomethylating agent, for the treatment of high-risk myelodysplastic syndrome: a multicenter phase II study in elderly patients","volume":"18","author":"Wijermans","year":"2000","journal-title":"J Clin Oncol"},{"key":"R10-20230916","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1160\/TH14-04-0342","article-title":"Low-dose decitabine promotes megakaryocyte maturation and platelet production in healthy controls and immune thrombocytopenia","volume":"113","author":"Zhou","year":"2015","journal-title":"Thromb Haemost"},{"key":"R11-20230916","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.ekir.2019.07.021","article-title":"Membranous glomerulonephritis with crescents","volume":"4","author":"Nikolopoulou","year":"2019","journal-title":"Kidney Int Rep"},{"key":"R12-20230916","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.ajkd.2014.02.018","article-title":"Membranous nephropathy with crescents: a series of 19 cases","volume":"64","author":"Rodriguez","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"R13-20230916","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1038\/bmt.2015.161","article-title":"The potential role of HLA-DRB1\u221711 in the development and outcome of haematopoietic stem cell transplantation-associated thrombotic microangiopathy","volume":"50","author":"Balassa","year":"2015","journal-title":"Blood Marrow Transplant"},{"key":"R14-20230916","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.kint.2018.06.005","article-title":"HLA class II alleles differing by a single amino acid associate with clinical phenotype and outcome in patients with primary membranous nephropathy","volume":"94","author":"Wang","year":"2018","journal-title":"Kidney Int"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022901","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,16]],"date-time":"2023-09-16T03:51:16Z","timestamp":1694836276000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000022901"}},"subtitle":["A case report"],"short-title":[],"issued":{"date-parts":[[2020,10,23]]},"references-count":14,"journal-issue":{"issue":"43","published-online":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000022901","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"type":"print","value":"0025-7974"},{"type":"electronic","value":"1536-5964"}],"subject":[],"published":{"date-parts":[[2020,10,23]]}}}